The FDA has refused to review Moderna's application to sell a new flu shot, the latest move by the administration against vaccines
ModernaModerna(US:MRNA) WSJ·2026-02-11 07:00

监管审查结果 - 公司表示监管机构将不会审查其申请 理由是测试该疫苗的研究不够充分 [1]

The FDA has refused to review Moderna's application to sell a new flu shot, the latest move by the administration against vaccines - Reportify